97944-43-9

Usage

Uses

Used in Pharmaceutical Industry:
4-Amino-5-bromo-3-methylpyridine is used as a key intermediate for the synthesis of pharmaceutical drugs. Its unique structure allows for the development of new drug candidates with potential therapeutic applications, contributing to the advancement of medicine.
Used in Agrochemical Industry:
In the agrochemical sector, 4-amino-5-bromo-3-methylpyridine is utilized as a precursor in the production of crop protection products. Its incorporation into these products aids in enhancing crop yield and quality by protecting plants from pests and diseases.
Used in Organic Synthesis:
4-Amino-5-bromo-3-methylpyridine is employed as a building block in organic synthesis across various chemical processes and industries. Its versatile reactivity enables the creation of a wide range of compounds for different applications, showcasing its importance in the field of chemistry.

InChI:InChI=1/C6H7BrN2/c1-4-2-9-3-5(7)6(4)8/h2-3H,1H3,(H2,8,9)

Upstream product

• 1990-90-5 4-amino-3-methylpyridine 

Downstream Products

• 183428-93-5 4-amino-3-cyano-5-methylpyridine 
• 845752-00-3 C₁₄H₁₂Cl₂N₂O 
• 845752-01-4 C₁₂H₇Cl₂N₃ 

Relevant academic research and scientific papers

NOVEL INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A

The present invention relates to novel carboxamide compounds, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating or controlling medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders

GABANERGIC MODULATORS

This invention relates to the use of compounds of benzoindazole derivatives salts and solvates thereof for the preparation of a medicament for modulating alpha2 subtype GABA A receptors. The invention further relates to novel heterocyclic compounds and pharmaceutical compositions containing said compounds. In addition the invention relates to the use of compounds of formula (I) salts and solvates thereof for the preparation of a medicament for the treatment of depression, an anxiety disorder, a psychiatric disorder, a learning or cognitive disorder, a sleep disorder, a convulsive or seizure disorder or pain.

Bromination of Pyridines. II. Bromination of Aminopicolines

The bromination of all ten possible aminopicolines 1-10 was investigated.In general, the major brominated product was that corresponding to electrophilic attack at the sites para or ortho to the amino group.